We need new treatment options to control bacterial infections. Bacteria use several
strategies to resist drug treatment, including modification of the drug target, and adaptation …

The discovery of penicillin and the tremendous success achieved in preventing fatalities due
to microbial infections by using it as a therapeutic antibiotic was perhaps the starting point of …

Our incessant tug-of-war with multidrug resistant pathogenic bacteria has prompted
researchers to explore novel methods of designing therapeutics in order to defend ourselves …

Antimicrobial peptides have been isolated and characterized from tissues and organisms
representing virtually every kingdom and phylum, ranging from prokaryotes to humans. Yet …

As antibiotic resistance increases worldwide, there is an increasing pressure to develop
novel classes of antimicrobial compounds to fight infectious disease. Peptide therapeutics …

With increasing antibiotics resistance, there is an urgent need for novel infection
therapeutics. Since antimicrobial peptides provide opportunities for this, identification and …

The antimicrobial resistance crisis is an ongoing major threat to public health safety. Low-
and middle-income countries are particularly susceptible to higher fatality rates and the …

The search for efficient antimicrobial therapies that can alleviate suffering caused by
infections from resistant bacteria is more urgent than ever before. Infections caused by multi …

The increasing number of antibiotic resistant bacterial strains presents an emerging world
health problem that demands continued effort to develop new antibacterial compounds …

Antimicrobial peptides are promising alternative antimicrobial agents. However, little is
known about whether resistance to small-molecule antibiotics leads to cross-resistance …